Register entry
- Registered sites
- 3
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- South Korea
Authorisation
Registered operations
Analytical testing3Active ingredient (API) manufacture2Finished drug manufacture3
Sites
Registered establishments
3| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Medytox Inc. | 78, Gangni-1gil, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do 28126, Korea, South (KOR) | Analytical testing, Finished drug manufacture | 3013347215688825256 |
| Medytox Inc. | 71, Osongsaengmyeong 6-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do 28158, Korea, South (KOR) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3015108961695289268 |
| Medytox Inc. | 102, Osongsaengmyeong 4-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do 28161, Korea, South (KOR) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3014451374695289750 |
Neighbours
Registered in the same town
1- Prestige Biologics Co., Ltd.Chungcheongbuk-do 28161, KOR
Compare
Comparable companies in South Korea
- Englewood Lab Korea Co Ltd2 sites · 11 NDC
- ST Pharm Co., Ltd.2 sites · 8 NDC
- Huons Co., Ltd.2 sites · 5 NDC
- Daewoong Pharmaceutical Co., Ltd.4 sites · 1 NDC
- High Tech Pharm Co., Ltd.2 sites · 0 NDC
- Prestige Biologics Co., Ltd.2 sites · 0 NDC
- Aekyung Industrial Co., Ltd.1 site · 64 NDC
- Amorepacific Group1 site · 53 NDC
- I World Pharmaceutical Co., Ltd.1 site · 48 NDC
- CELLTRION Inc1 site · 36 NDC
Enquiry
Common questions
- Is Medytox Inc. FDA approved?
- Medytox Inc. holds 3 FDA-registered establishments in South Korea. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Medytox Inc.'s drugs manufactured?
- The FDA register lists Chungcheongbuk-do 28126; Chungcheongbuk-do 28158; Chungcheongbuk-do 28161. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.